Roche and Eli Lilly to collaborate on early Alzheimer's detection test

Swiss pharmaceutical company Roche and US-based Eli Lilly have joined forces to continue development of the former company’s Elecsys Amyloid Plasma Panel (EAPP) – an innovative blood test ”that aims to facilitate the earlier diagnosis of Alzheimer’s disease.”
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Eli Lilly Alzheimer’s drug fails to prevent disease in trial
For subscribers